Maurizio Martelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study	INFECTION AND DRUG RESISTANCE	2023
Late appearance of JAK2 mutated polycythaemia vera in a patient with typical chronic myeloid leukaemia on imatinib: Speculations about role of therapeutic pressure and of secondary genetic events	LEUKEMIA RESEARCH	2023
Whole body MRI with Difusion Weighted Imaging versus 18F‑fuorodeoxyglucose‑PET/CT in the staging of lymphomas	LA RADIOLOGIA MEDICA	2023
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia	CANCERS	2023
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas	LA RADIOLOGIA MEDICA	2023
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study	JOURNAL OF CLINICAL MEDICINE	2023
Case Report: Infectious prophylaxis in hematological malignancies	FRONTIERS IN ONCOLOGY	2023
Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients?	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2023
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel	HEMASPHERE	2023
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA	2023
Impact of gemtuzumab ozogamicin consolidation on hematopoietic stem cells (HSCs) mobilization in AML: analysis of 20 patients	ANNALS OF HEMATOLOGY	2023
Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination	FRONTIERS IN ONCOLOGY	2023
Asciminib as a third line option in chronic myeloid leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY	2023
Editorial: HBV and lymphoma	FRONTIERS IN ONCOLOGY	2023
CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases	LEUKEMIA & LYMPHOMA	2023
Myelodysplastic clones arising post chimeric antigen receptor t cell therapy (car-t) procedure: a casuality or a new entity?	ANNALS OF HEMATOLOGY	2023
Systemic mastocytosis: 2023 update on diagnosis and management in adults	EXPERT OPINION ON EMERGING DRUGS	2023
Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS	FRONTIERS IN ONCOLOGY	2023
One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission	EUROPEAN JOURNAL OF HAEMATOLOGY	2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy	ANNALS OF HEMATOLOGY	2023